GO:0008203 cholesterol metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008203 cholesterol metabolic process describes all chemical reactions and pathways involving cholesterol, the principal sterol of vertebrates and precursor of bile acids and steroid hormones.
• Cholesterol is essential for plasma membrane integrity, lipid raft signaling, and lipoprotein assembly, and its metabolism is tightly regulated at synthesis, uptake, efflux, and conversion steps.
• Key genes include HMGCR, LDLR, SCARB1, ABCA1, ABCG1, CYP7A1, SOAT1, and NR1H2/NR1H3, which control synthesis, uptake, efflux, esterification, and bile acid production.
• Dysregulated cholesterol metabolism contributes to atherosclerosis, cancer radioresistance, ferroptosis evasion, and reproductive aging.
• Cholesterol metabolites and intermediates also act as signaling molecules that shape immune cell function, including regulatory T cell specialization in tumors.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of cholesterol metabolic genes in disease and drug discovery.
Description
Cholesterol metabolic process (GO:0008203) encompasses the chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues. Because cholesterol is both a structural lipid and a precursor for signaling molecules, its metabolism is central to membrane biology, endocrine function, and cardiovascular health. Researchers study this process to understand how cells balance de novo synthesis, uptake, esterification, efflux, and conversion into bile acids and steroid hormones. Dysregulation of cholesterol metabolic process is linked to atherosclerosis, tumor radioresistance, ferroptosis inhibition, and age-related oocyte quality decline, making it a high-value target for mechanistic and therapeutic studies. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the pathway, key genes, regulation, disease links, and experimental models for GO:0008203.
cholesterol metabolic process At A Glance
| GO ID | GO:0008203 |
|---|---|
| GO term | cholesterol metabolic process |
| Ontology | biological_process |
| Synonym | cholesterol metabolism |
| Definition | The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. |
| Major function | Maintains membrane structure and fluidity, supports lipid raft signaling, provides precursor for bile acids and steroid hormones, and regulates lipoprotein metabolism. |
| Cellular locations | Plasma membrane lipid bilayer, endoplasmic reticulum, lipid droplets, plasma lipoproteins, and all animal tissues. |
| Key substrates | Acetyl-CoA for synthesis, LDL and HDL particles for transport, cholesterol itself for esterification and conversion. |
| Key products | Cholesteryl esters, bile acids, oxysterols, and steroid hormones. |
What Is GO:0008203?
GO:0008203 cholesterol metabolic process is defined as the chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. Cholesterol is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues. In practice, this term covers cholesterol biosynthesis, uptake, intracellular transport, esterification, efflux, and enzymatic conversion to oxysterols, bile acids, and steroid hormones.
Why Is cholesterol metabolic process Important in Cell Biology?
Cholesterol metabolic process is fundamental to cell physiology because cholesterol is the principal sterol of vertebrates and a precursor of bile acids and steroid hormones. It controls membrane organization, lipid raft signaling, and lipoprotein assembly, and its dysregulation is causally linked to atherosclerosis, cancer progression, ferroptosis resistance, and reproductive aging. Understanding GO:0008203 therefore informs cardiovascular biology, oncology, immunometabolism, and drug development.
• Cholesterol is the principal sterol of vertebrates and a precursor of bile acids and steroid hormones.
• It is a structural component of the plasma membrane lipid bilayer and plasma lipoproteins.
• Cholesterol metabolism controls membrane fluidity and lipid raft signaling.
• Dysregulated cholesterol metabolism contributes to atherosclerosis and cardiovascular disease.
• Cholesterol metabolism-mediated ferroptosis inhibition promotes tumor radioresistance.
• Cholesterol metabolites influence regulatory T cell specialization in tumors.
• Abnormal cholesterol-cholesteryl ester metabolism impairs oocyte quality during ovarian aging.
• Macrophage cholesterol efflux and lipophagy are key processes in foam cell formation.
• Bile acid synthesis from cholesterol is a major route for cholesterol elimination.
• Cholesterol metabolic genes are tractable targets for CRISPR-based functional genomics.
What Happens During cholesterol metabolic process?
Cholesterol Biosynthesis
In simple terms: Cells build cholesterol from simple building blocks in a multi-step enzymatic assembly line.
Cholesterol biosynthesis converts acetyl-CoA into cholesterol through the mevalonate pathway, with HMGCR as the rate-limiting enzyme. This process is energetically expensive and tightly regulated by sterol feedback, ensuring that membrane and precursor demands are met without excessive accumulation. The pathway also generates intermediates such as isoprenoids that support other cellular functions.
Cholesterol Uptake and Transport
In simple terms: Cells take up cholesterol from lipoproteins and move it between compartments.
LDLR mediates uptake of LDL-derived cholesterol, while SCARB1 (SR-BI) facilitates HDL cholesterol uptake and influences ferroptosis sensitivity and radioresistance. Intracellular cholesterol is transported between the plasma membrane, endoplasmic reticulum, and lipid droplets, where it can be stored as cholesteryl esters. Lipophagy and lipid droplet factors regulate cholesterol efflux in macrophage foam cells.
Cholesterol Esterification and Storage
In simple terms: Cells convert cholesterol into a storage form to prevent toxicity and manage supply.
SOAT1 and SOAT2 esterify cholesterol to cholesteryl esters for storage in lipid droplets, a process that buffers free cholesterol levels. Abnormal cholesterol-cholesteryl ester metabolism impairs mouse oocyte quality during ovarian aging, highlighting the importance of esterification balance in reproduction. Lipid droplet-associated factors regulate lipophagy and cholesterol efflux in macrophages.
Cholesterol Efflux and Reverse Transport
In simple terms: Cells export excess cholesterol to carriers that return it to the liver.
ABCA1 and ABCG1 mediate cholesterol efflux to lipid-poor apolipoproteins and HDL, initiating reverse cholesterol transport. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing PPAR alpha and fundamentally changing lipid metabolism, illustrating how efflux and lipid handling are integrated. Defective efflux promotes foam cell formation and atherosclerosis.
Bile Acid Synthesis and Steroidogenesis
In simple terms: Cholesterol is converted into bile acids and steroid hormones for digestion and signaling.
CYP7A1 catalyzes the rate-limiting step of bile acid synthesis, the major pathway for cholesterol elimination. Bile acids also act as signaling molecules that regulate their own synthesis and metabolic homeostasis. Cholesterol is also the precursor for steroid hormones, linking GO:0008203 to endocrine function.
Key Genes Involved in GO:0008203 cholesterol metabolic process
The following genes and proteins are central to cholesterol metabolic process (GO:0008203) and are widely studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGCR | Rate-limiting enzyme of cholesterol biosynthesis | Target of statins; central to synthesis regulation |
| LDLR | Mediates LDL cholesterol uptake | Mutations cause familial hypercholesterolemia; drug target |
| SCARB1 | HDL cholesterol uptake receptor | Links cholesterol metabolism to ferroptosis inhibition and radioresistance |
| ABCA1 | Cholesterol efflux to apolipoproteins | Defects cause Tangier disease; atherosclerosis research |
| ABCG1 | Cholesterol efflux to HDL | Macrophage foam cell and reverse transport studies |
| CYP7A1 | Rate-limiting enzyme of bile acid synthesis | Cholesterol elimination and bile acid signaling |
| SOAT1 | Cholesterol esterification for storage | Lipid droplet and cholesteryl ester metabolism |
| SOAT2 | Intestinal cholesterol esterification | Dietary cholesterol absorption research |
| NR1H2 | LXR beta; regulates cholesterol efflux genes | Transcriptional control of reverse transport |
| NR1H3 | LXR alpha; regulates cholesterol efflux genes | Target for atherosclerosis and lipid disorders |
| SREBF2 | Master transcription factor of cholesterol synthesis | Feedback regulation of HMGCR and LDLR |
| NPC1L1 | Intestinal cholesterol absorption | Target of ezetimibe; cholesterol uptake studies |
| APOE | Lipoprotein component; cholesterol transport | Alzheimer's disease and cardiovascular risk |
| CYP27A1 | Sterol 27-hydroxylase; bile acid synthesis | Alternative bile acid pathway; oxysterol signaling |
| ABCA1 | Cholesterol efflux pump | Macrophage lipophagy and efflux studies |
| ACE | Angiotensin-converting enzyme; lipid metabolism regulator | Atherosclerosis and PPAR alpha signaling |
| SCARB1 | HDL receptor | Tumor radioresistance and ferroptosis |
How Is cholesterol metabolic process Regulated?
Cholesterol metabolic process is regulated at multiple levels. SREBP-2 controls transcription of cholesterol biosynthetic genes such as HMGCR and LDLR in response to sterol levels. LXR alpha and LXR beta (NR1H3 and NR1H2) induce efflux genes including ABCA1 and ABCG1 when cellular cholesterol is high. Bile acid synthesis via CYP7A1 is feedback-inhibited by bile acids through FXR signaling, maintaining cholesterol elimination balance. Macrophage angiotensin-converting enzyme modulates PPAR alpha and broadly changes lipid metabolism, linking renin-angiotensin signaling to cholesterol handling. Lipid droplet factors and lipophagy regulate cholesterol efflux in foam cells, adding post-transcriptional control.
cholesterol metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCARB1 | Tumor radioresistance and ferroptosis inhibition | Knockout and overexpression in cancer cell lines |
| ABCA1 | Tangier disease and atherosclerosis | Knockout macrophages and efflux assays |
| CYP7A1 | Bile acid synthesis disorders and cholesterol gallstones | Knockout hepatocyte models and bile acid profiling |
| SOAT1 | Ovarian aging and oocyte quality decline | Knockout mouse oocytes and cholesteryl ester measurement |
| ACE | Atherosclerosis and lipid metabolism | Knockout macrophage models and PPAR alpha readouts |
Atherosclerosis and Cardiovascular Disease
Defective cholesterol efflux and excessive uptake promote macrophage foam cell formation and atherosclerosis. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing PPAR alpha and fundamentally changing lipid metabolism, demonstrating that cholesterol handling pathways are modifiable disease drivers. Reverse cholesterol transport and bile acid synthesis are protective routes for cholesterol elimination.
Cancer Radioresistance and Ferroptosis
SCARB1 links cholesterol metabolism-mediated ferroptosis inhibition to radioresistance in tumor cells, suggesting that cholesterol uptake pathways can be targeted to sensitize tumors to therapy. Cholesterol metabolites also enforce functional specialization of regulatory T cells in tumors, connecting cholesterol metabolism to immune evasion.
Reproductive Aging
Abnormal cholesterol-cholesteryl ester metabolism impairs mouse oocyte quality during ovarian aging, indicating that cholesterol storage and esterification balance are required for oocyte competence. This links GO:0008203 to reproductive biology and age-related fertility decline.
Metabolic and Neurodegenerative Disorders
Cholesterol metabolism is a metabolically important molecule in human physiology, and its dysregulation is associated with metabolic disorders. APOE, a key cholesterol transport protein, is a major genetic risk factor in Alzheimer's disease and cardiovascular disease, linking GO:0008203 to neurodegeneration.
From cholesterol metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SCARB1 alter ferroptosis sensitivity and radioresistance? | CRISPR knockout in tumor cell lines |
| Does a point mutation in LDLR impair cholesterol uptake? | Point-mutation knock-in in hepatocytes |
| Can ABCA1 overexpression restore cholesterol efflux? | Overexpression cell model in macrophages |
| How does SOAT1 loss affect oocyte cholesteryl ester stores? | Knockout mouse oocytes |
| Does CYP7A1 knockout change bile acid synthesis? | Knockout hepatocyte model |
| Can tagged HMGCR track synthesis regulation? | Tagged knock-in for imaging and proteomics |
How to Study the cholesterol metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Free cholesterol, cholesteryl esters, oxysterols | Quantify cholesterol metabolic flux |
| RNA-seq | Transcript levels of cholesterol genes | Pathway response to perturbation |
| Proteomics | Protein abundance and interactions | Lipid droplet and efflux factor discovery |
| Cholesterol efflux assay | Export of cholesterol to acceptors | ABCA1/ABCG1 function |
| Bile acid profiling | Bile acid species and synthesis rate | CYP7A1 pathway activity |
| Fluorescence imaging | Cholesterol and lipid droplet distribution | Subcellular localization studies |
| Ferroptosis assay | Lipid peroxidation and cell death | SCARB1-mediated radioresistance |
| Radio resistance clonogenic assay | Survival after irradiation | Tumor therapy response |
Lipidomics and Cholesterol Quantification
Mass spectrometry-based lipidomics and enzymatic cholesterol assays quantify free cholesterol, cholesteryl esters, and oxysterols to assess GO:0008203 activity. These methods are essential for measuring the balance between synthesis, esterification, and efflux.
Transcriptomics and Pathway Analysis
RNA-seq and pathway enrichment identify expression changes in HMGCR, LDLR, ABCA1, ABCG1, and CYP7A1 under genetic or pharmacological perturbation. This approach links cholesterol metabolic process to broader transcriptional programs.
Proteomics and Interaction Mapping
Proteomic profiling of lipid droplet and membrane fractions identifies factors regulating lipophagy and cholesterol efflux in macrophage foam cells. Interaction mapping helps define how SCARB1, ABCA1, and ACE coordinate cholesterol handling.
Imaging and Functional Assays
Fluorescent cholesterol probes, lipid droplet staining, and efflux assays visualize cholesterol distribution and transport in live cells. These functional readouts complement CRISPR perturbations to establish causality.
How CRISPR Can Be Used to Study GO:0008203 cholesterol metabolic process
Knockout
CRISPR knockout of HMGCR, LDLR, SCARB1, ABCA1, or CYP7A1 enables loss-of-function studies of cholesterol synthesis, uptake, efflux, and bile acid production. Knockout models are used to test whether a gene is required for ferroptosis inhibition, radioresistance, or foam cell formation.
Point Mutation
Point-mutation knock-in can model disease-associated variants in LDLR, ABCA1, or SCARB1 to dissect how single amino acid changes alter cholesterol transport and signaling. These models are valuable for genotype-phenotype correlation in cardiovascular and metabolic disease.
Knock-in
Tagged knock-in of HMGCR, SOAT1, or ABCA1 with fluorescent or affinity tags allows real-time tracking of cholesterol metabolic enzymes and their interactors. Knock-in reporters also enable precise measurement of pathway activity in live cells.
Overexpression
Overexpression of ABCA1, ABCG1, or SCARB1 tests sufficiency for cholesterol efflux, ferroptosis inhibition, or radioresistance. Overexpression models complement knockout studies to establish bidirectional causality in GO:0008203.
How EDITGENE Supports cholesterol metabolic process Research
Researchers studying cholesterol metabolic process-related genes often need to determine whether a candidate gene is causally involved in synthesis, uptake, efflux, or disease phenotypes. EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression cell models, and CRISPR library screening with bioinformatics to accelerate functional validation of GO:0008203 genes.
Contact EDITGENE today to design your custom CRISPR model for cholesterol metabolic process research.
Frequently Asked Questions About cholesterol metabolic process
What is cholesterol metabolic process GO:0008203?
GO:0008203 is the biological process comprising the chemical reactions and pathways involving cholesterol, the principal sterol of vertebrates and precursor of bile acids and steroid hormones.
What genes are involved in cholesterol metabolic process?
Key genes include HMGCR, LDLR, SCARB1, ABCA1, ABCG1, CYP7A1, SOAT1, NR1H2, NR1H3, SREBF2, NPC1L1, APOE, CYP27A1, and ACE.
Why is cholesterol metabolism important for cells?
Cholesterol is a structural component of the plasma membrane and lipoproteins and a precursor of bile acids and steroid hormones, making its metabolism essential for membrane function and signaling.
How is cholesterol metabolic process regulated?
It is regulated by SREBP-2 for synthesis, LXR alpha and LXR beta for efflux, and bile acid feedback on CYP7A1, among other mechanisms.
What diseases are linked to cholesterol metabolism?
Atherosclerosis, cancer radioresistance, ferroptosis inhibition, reproductive aging, and neurodegenerative disorders are linked to cholesterol metabolic process.
How do you study cholesterol metabolic process in the lab?
Common methods include lipidomics, RNA-seq, proteomics, cholesterol efflux assays, bile acid profiling, imaging, and ferroptosis assays.
Can CRISPR be used to study cholesterol metabolism genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect cholesterol metabolic gene function.
What is the role of SCARB1 in cholesterol metabolism?
SCARB1 mediates HDL cholesterol uptake and links cholesterol metabolism to ferroptosis inhibition and radioresistance in tumor cells.
How does cholesterol metabolism affect immune cells?
Cholesterol metabolites enforce functional specialization of regulatory T cells in tumors, linking cholesterol metabolism to immune regulation.
What is the relationship between cholesterol metabolism and oocyte quality?
Abnormal cholesterol-cholesteryl ester metabolism impairs mouse oocyte quality during ovarian aging.
Conclusion
GO:0008203 cholesterol metabolic process is a central biological process that governs cholesterol synthesis, uptake, transport, esterification, efflux, and conversion into bile acids and steroid hormones. Its dysregulation is implicated in atherosclerosis, cancer radioresistance, ferroptosis inhibition, reproductive aging, and metabolic disease. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with lipidomics, transcriptomics, proteomics, and imaging, provide powerful tools to dissect the causal roles of cholesterol metabolic genes. EDITGENE supports these efforts with custom cell model generation, library screening, and bioinformatics tailored to GO:0008203 research.
References
- 1. Schade DS et al.. 2020. Cholesterol Review: A Metabolically Important Molecule.. Endocr Pract 26(12):1514-1523 PMID: 33471744
- 2. Chiang JY. 2013. Bile acid metabolism and signaling.. Compr Physiol 3(3):1191-212 PMID: 23897684
- 3. Cui D et al.. 2025. Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets.. Mol Biomed 6(1):72 PMID: 41062796
- 4. Robichaud S et al.. 2021. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.. Autophagy 17(11):3671-3689 PMID: 33590792
- 5. Zhang S et al.. 2025. Abnormal cholesterol-cholesteryl ester metabolism impairs mouse oocyte quality during ovarian aging.. Cell Mol Biol Lett 30(1):140 PMID: 41286604
- 6. Lim SA et al.. 2021. Lipid signalling enforces functional specialization of T(reg) cells in tumours.. Nature 591(7849):306-311 PMID: 33627871
- 7. Mao X et al.. 2025. SCARB1 links cholesterol metabolism-mediated ferroptosis inhibition to radioresistance in tumor cells.. J Adv Res 77:207-219 PMID: 39832721
- 8. Cao D et al.. 2023. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism.. Cardiovasc Res 119(9):1825-1841 PMID: 37225143
